Raymond James & Associates’s Stoneridge SRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-16,141
Closed -$302K – 3964
2023
Q1
$302K Buy
16,141
+2,073
+15% +$44.5K ﹤0.01% 3239
2022
Q4
$303K Buy
14,068
+1,565
+13% +$33.5K ﹤0.01% 3207
2022
Q3
$212K Buy
12,503
+1,534
+14% +$28.8K ﹤0.01% 3413
2022
Q2
$188K Sell
10,969
-2,690
-20% -$51.1K ﹤0.01% 3527
2022
Q1
$284K Buy
+13,659
New +$251K ﹤0.01% 3448
2018
Q4
– Sell
-13,012
Closed -$387K – 3682
2018
Q3
$387K Sell
13,012
-12,292
-49% -$390K ﹤0.01% 2876
2018
Q2
$889K Buy
+25,304
New +$769K ﹤0.01% 2296

Other funds holding SRI

Raymond James & Associates's SRI Position: Q2 2023 in Review

Raymond James & Associates sold out of Stoneridge (SRI) in Q2 2023, closing a stake of 16,141 shares — an estimated $302K sold.

Raymond James & Associates first reported a position in SRI in Q2 2018 and held it in 7 quarters. The position peaked at $889K in Q2 2018. 113 funds tracked by Wall St. Rank hold SRI as of Q2 2023.

  • Raymond James & Associates reported no remaining Stoneridge position as of Q2 2023 after selling out during the quarter.
  • Raymond James & Associates sold 16,141 Stoneridge shares in Q2 2023, an estimated $302K.
  • Raymond James & Associates first reported a position in Stoneridge in Q2 2018 and held it in 7 quarters.
  • Raymond James & Associates's Stoneridge position peaked at $889K in Q2 2018.
  • 113 funds tracked by Wall St. Rank held Stoneridge as of Q2 2023.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.